Re: Retention Bonus AgreementRetention Bonus Agreement • March 19th, 2009 • Cortex Pharmaceuticals Inc/De/ • Pharmaceutical preparations
Cortex Pharmaceuticals, Inc. (together with any successor thereto or, if applicable, the ultimate parent of any such successor, the “Company”) considers it essential to the best interests of its stockholders to foster the continuous employment of the Company’s key personnel. In this regard, the Company’s Compensation Committee of the Board of Directors (the “Committee”) recognizes that the possibility of a change of control of the Company may exist and the uncertainty and questions that it may raise among key employees could result in the departure or distraction of these personnel to the detriment of the Company, its stockholders, and the potential purchaser of the company.
